Skip to main content

Peer Review reports

From: Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report

Original Submission
10 Feb 2016 Submitted Original manuscript
7 Jan 2017 Reviewed Reviewer Report - Antonis Valachis
2 Apr 2017 Author responded Author comments - Santino Minichillo
Resubmission - Version 2
2 Apr 2017 Submitted Manuscript version 2
16 Apr 2017 Reviewed Reviewer Report - Antonis Valachis
26 Jun 2017 Author responded Author comments - Santino Minichillo
Resubmission - Version 3
26 Jun 2017 Submitted Manuscript version 3
2 Aug 2017 Author responded Author comments - Santino Minichillo
Resubmission - Version 4
2 Aug 2017 Submitted Manuscript version 4
13 Sep 2017 Author responded Author comments - Santino Minichillo
Resubmission - Version 5
13 Sep 2017 Submitted Manuscript version 5
8 Oct 2017 Author responded Author comments - Santino Minichillo
Resubmission - Version 6
8 Oct 2017 Submitted Manuscript version 6
Publishing
30 Oct 2017 Editorially accepted
7 Nov 2017 Article published 10.1186/s12885-017-3712-8

You can find further information about peer review here.

Back to article page